Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.655 USD | +1.34% | -24.68% | +14.44% |
05-09 | Transcript : Mersana Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
05-09 | Earnings Flash (MRSN) MERSANA THERAPEUTICS Posts Q1 Revenue $9.2M, vs. Street Est of $8.5M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.44% | 321M | |
+4.42% | 111B | |
+11.19% | 105B | |
-12.11% | 22.34B | |
-3.93% | 21.93B | |
-6.03% | 18.59B | |
-35.21% | 18.12B | |
-9.23% | 16.96B | |
+3.08% | 13.7B | |
+36.30% | 12.45B |
- Stock Market
- Equities
- MRSN Stock
- News Mersana Therapeutics, Inc.
- Wedbush Upgrades Mersana Therapeutics to Outperform From Neutral, Notes Increased Confidence in Program; Adjusts PT to $7 From $2